Canadian experts strongly recommend COVID vaccines in pregnancy amid U.S. policy changes
Article content
Canadian health experts are doubling down on their support of COVID-19 vaccines for pregnant women amid U.S. policy changes announced by Health Secretary Robert F. Kennedy Jr. this week.
Article content
Article content
The Society of Obstetricians and Gynecologists of Canada issued a statement reaffirming that COVID-19 vaccines were both safe and recommended during pregnancy and breastfeeding and urging people to make vaccine decisions based on science and expertise.
Article content
Article content
'In an age of growing misinformation and disinformation, the SOGC strongly urges that vaccine decisions, including during pregnancy, be guided by evidence-based science and clinical expertise.'
Article content
Article content
Pregnant women with COVID-19 are more likely to end up in hospital, need intensive care or require ventilators compared to other women of the same age who are not pregnant, the SOGC statement said. 'Receiving the COVID-19 vaccine helps lower the chances of serious complications for pregnant women, including intensive care admission, the need for a ventilator, preterm birth and death.'
Article content
The extraordinary statement from the organization underscores the concern about the potential impact of some U.S. health policy changes on vaccine uptake and understanding in Canada as well as the United States.
Article content
Kennedy's announcement that the COVID-19 vaccine would no longer be recommended for pregnant women and healthy children was met with concern by many health officials in the U.S. and beyond.
Article content
Article content
The American College of Obstetricians and Gynecologists said it was extremely disappointed by the announcement, adding 'we have seen firsthand how dangerous COVID-19 infection can be during pregnancy and for newborns who depend on maternal antibodies from the vaccine for protection.'
Article content
Article content
Dr. Darine El-Chaar, a maternal-fetal medicine physician at The Ottawa Hospital, said the U.S. policy was not based on any scientific evidence or medical concerns.
Article content
'There is no clinical or scientific reason.'
Article content
She said another key concern was how much misinformation and confusion the U.S. policy change could create, possibly leading to vaccine hesitation around COVID-19 and other vaccines recommended during pregnancy to protect mothers and babies. Those include vaccines for influenza, RSV and whooping cough.
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
an hour ago
- Toronto Star
FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
CBC
5 hours ago
- CBC
3 apps that can save you money on supper tonight while also fighting food waste
Did you know Canadian households produce an average of nearly 80 kilograms of food waste every year? That's on top of the nearly 1.31 million tonnes of food that grocery stores toss out annually. All that rotting food is harming the environment, and wasting money, during a time of food insecurity and skyrocketing prices. But there are ways to do your part to prevent food waste and save cash in the process. Listen below to learn about three apps you can use to save money on your meals tonight — and save that food from being tossed into a dumpster. Love deals? Click here for more Deal Diva segments for more great tips on saving money.
